319 results
Page 11 of 16
8-K
EX-99.1
wkmxii8 mm
31 Mar 21
Yumanity Therapeutics Reports Full Year 2020 Financial Results and Recent Corporate Developments
8:55am
424B3
rut5w4sjvyhlk
11 Feb 21
Prospectus supplement
4:55pm
8-K
EX-99.1
23ut 94p5e
10 Feb 21
Yumanity Therapeutics Provides Update on Its Lead Parkinson’s Disease Clinical Program, YTX-7739
8:13am
8-K/A
EX-99.7
k4oi5ulz1ht0wqwobao9
3 Feb 21
Other Events
4:59pm
8-K/A
EX-99.4
2wousp50wtsw
3 Feb 21
Other Events
4:59pm
8-K/A
EX-99.3
rzjfo7zxi31kmq ps9s
3 Feb 21
Other Events
4:59pm
8-K/A
EX-99.6
6aevnnz5
3 Feb 21
Other Events
4:59pm
8-K/A
EX-99.1
fsmq2cqmkdxxg9k
3 Feb 21
Other Events
4:59pm
8-K/A
EX-99.2
0naxq8m7cssz8p
3 Feb 21
Other Events
4:59pm
8-K
EX-10.1
neriduozsxaa5xqd3t
30 Dec 20
Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics
4:44pm
8-K
EX-10.6
hdss2i3 77n1z
30 Dec 20
Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics
4:44pm
8-K
EX-99.1
bd9casxd12zbk7y x1
30 Dec 20
Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics
4:44pm
8-K
EX-10.5
uor989jitv0
30 Dec 20
Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics
4:44pm
8-K
EX-10.2
rx3u19ox g3j0qi
30 Dec 20
Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics
4:44pm
8-K
EX-10.2
waqlpe ccqj
15 Dec 20
Yumanity Therapeutics to Raise $33.6 Million PIPE Contingent on Completion of Reverse Merger with Proteostasis
7:34am
8-K
5j4uy nsxnx1
15 Dec 20
Yumanity Therapeutics to Raise $33.6 Million PIPE Contingent on Completion of Reverse Merger with Proteostasis
7:34am
8-K
EX-99.1
zwdf hh9odvf
15 Dec 20
Yumanity Therapeutics to Raise $33.6 Million PIPE Contingent on Completion of Reverse Merger with Proteostasis
7:34am
8-K
EX-10.1
9gk t7knn02o13
15 Dec 20
Yumanity Therapeutics to Raise $33.6 Million PIPE Contingent on Completion of Reverse Merger with Proteostasis
7:34am